MedGenome Licenses Natera NIPT Technology for India | GenomeWeb

NEW YORK (GenomeWeb) – Clinical genomic testing firm MedGenome and Natera have reached an exclusive agreement to provide Natera's Panorama non-invasive prenatal test in India.

Under the terms of the agreement, MedGenome will have a license to develop the capacity of and to perform the test, which screens for trisomies, 21, 18, and 13, and certain sex chromosome abnormalities, such as monosomy X.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.